Vascular protection with newer antihypertensive agents

Journal of Hypertension, Supplement

Volumn 16, Issue 5, 1998, Pages

  Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

blockers; Angiotensin converting enzyme inhibitors; Calcium antagonists; Essential hypertension; Small arteries; Vascular hypertrophy; Vascular remodeling

Indexed keywords

ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM ANTAGONIST; CALCIUM ION; CATECHOLAMINE; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; NITRIC OXIDE SYNTHASE; PEPTIDE;

ARTERY; ARTERY MEDIA; BLOOD VESSEL; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; FOREARM BLOOD FLOW; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTECTION; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE;

ANTIHYPERTENSIVE AGENTS; ARTERIES; BLOOD VESSELS; HUMANS; HYPERTENSION; MICROCIRCULATION;

EID: 0031771151     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Bohlen HG. Localization of vascular resistance changes during hypertension. Hypertension 1986;8:181-183.
2. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990;70:922-961.
3. Schiffrin EL. Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture. Hypertension 1992;19 (suppl II): II-1-II-9.
4. Brush JE Jr, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-1307
5. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987;61:181-186.
6. Schiffrin EL, Deng LY, Larochelle P. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993;16:177-186.
7. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, et al. Vascular remodeling [letter]. Hypertension 1996;28:505-506.
8. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993;22:523-526.
9. Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertens 1992;10:437-444.
10. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986;8 (suppl II):II-61-II-66.
11. 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-461.
12. Touyz RM, Tolloczko B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1. J Hypertens 1994;12:663-673.
13. Dohi Y, Criscione L, Pfeiffer K, Lüscher TF. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994; 24:372-379.
14. Li J-S, Schiffrin EL. Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR. J Cardiovasc Pharmacol 1996;28:68-74.
15. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990; 16:603-614.
16. Deng LY, Schiffrin EL. Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats. J Cardiovasc Pharmacol 1993; 21:725-731.
17. Shaw LM, George PR, Oldnam AA, Heagerty AM. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries. J Hypertens 1995; 13:1135-1143.
18. G-monomethyl-L-arginine in patients with essential hypertension. J Hypertens 1994;12:1047-1052.
19. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens 1996; 14:1247-1255.
20. Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
21. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a β-blocker. Am J Hypertens 1995;8:229-236.
22. Schiffrin EL, Deng L-Y. Comparison of effects of angiotensin I-converting enzyme inhibition and β-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995;25:699-703.
23. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-481.
24. Agabiti-Rosei E, Muiesan ML, Rizzoni D, Zulli R, Calebich S, Castellano M, et al. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension. J Cardiovasc Pharmacol 1994;24 (suppl A):S37-S43.
25. Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, et al. Media : lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995;13:341-347.
26. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994;23:659-666.
27. Schiffrin EL. Effect of antihypertensive therapy on small artery structure in hypertensive patients [letter]. Hypertension 1995;26:716-718.
28. Virdis A, Ghiadoni L, Lucarini A, Di Legge V, Taddei S, Salvetti A. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment. Am J Hypertens 1996;9:361-369.
29. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996;27:1031-1038.